This site is intended for health professionals only
Wednesday 22 May 2019
Share |

Pregabalin and gabapentin reclassified as controlled drugs

The change follows concerns around fatalities resulting from the misuse of the medicines

Pregabalin and gabapentin will be reclassified as Class C controlled drugs from 1 April, 2019.
The change means doctors will have to physically sign prescriptions for the drugs, rather than sending electronic copies, and pharmacists must dispense within 28 days of the prescription being written.
The drugs, which can be used to treat anxiety, nerve pain and epilepsy, will be included in the ‘exempted drugs’ list, which means they do not need to be stored in a controlled drugs cabinet.
However, both will be subject to the prescription writing requirements for schedule 3 controlled drugs, which means to be valid prescriptions must include the dose, the form, the strength (where appropriate) and the total quantity or dosage units of the preparation in both words and figures.
The change is in response to concerns around the misuse of the drugsand will be made under amendments to the Misuse of Drugs Regulations (2001) and the Safe Custody Regulations (1973).

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher